Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They paid it in stock... so that's some more dilution.
Nice action today. Good volumes lately...
With just 80K shares unloaded? You know that this kind of things happens with a low float stock.
Anyway I was wrong with my entry... but a couple buys at the ask will send me to green again.
Guess what may happen with 10K$ worth of buying!
Ok thanks!
I didn't intend the registration of the stock, but the entity status of the company.
When the entity status of a shell company seeking for a reverse merger becomes 'inactive' is it a good sign?
I've been filled some shares at 0.045, so here I am! Lets hope I didn't buy too high... shares are tight and the market cap is 240K$ now, so it shouldn't be a bad entry point.
Please, send me the info at palple at hotmail.it
Thanks.
+50% with 250$ traded (of which the half at bid). Guess what may happen with 25K$ traded!
Some impatient unloaded today.
I think that he was only pissed by some posts here (and even more on the other board). He doesn't want to post on message boards so I'm not sure he'll post again, anyway I really think that it's the time to put out a shareholder letter (like last year by this time).
Just read what I told d1online just yesterday... if you are impatient and you dump at bid, then on this kind of stock you'll sell at a great discount only to see the price go back up in a small buy trade!
Someone unloaded at bid... on low os stocks people must learn that selling at bid or buying at ask is a fast way to lose the money...
You know, lifestem is only one of the division of Calbatech, and it's not the one that made it possible to generate a net income in 2006 since it generated almost no revenues.
I only know that the medspa in California is accepting stemcell banking, but I don't know how much did they process.
I'm pretty sure the so called ceo is really the ceo, and I'm pretty sure he is not going to post here anymore (because someone made him notice about the insider info problem...)
If you want to sell, it's your money and it's your right, I cannot suggest you what to do. The only thing I may suggest you - from my past experience with low float and low volumes stocks - is that if you want to sell,
1) there's often a big gap between the bid and the ask, and even though it can take some days to fill your sell order, try to sell at the ask: with only a small amount of bid whacking on this kind of stocks you risk to sell your shares at a big discount only to discover that the price goes back up with small trades just the day after you sold (it sadly happened a lot of times to me).
2) just take a look at the weekly chart, it's at a turning point, and without bad events (but what can be worse than the present situation?) this has a lot of chance to go somewhat up http://stockcharts.com/h-sc/ui?s=CLBE&p=W&yr=1&mn=0&dy=0&id=p80969640661
Nope it's not the moderator that called the medspas
Some months ago, late in 2006, someone (trusty) on another (the other) board called one of the medspas in California and yes, they were collecting stemcells for lifestem, although back then the number of clients was very small.
We didn't get much data on lifestem revenues in the latest filings so I think that it's a very small number of people. But they hadn't promoted LifeStem since then, except for the new website and a couple of prs last year.
If METP reverse merged with a company worth 30M$, then the share price could have climbed to dollar land, hence everyone was buying shares on rumor.
Look at USSE: once they reverse merged with LFZA, the market cap slowly climbed to 400 million dollars, and whoever bought million of shares in pennyland on the first trading days was gold.
GoldSilverMines explanation doesn't convince me at all because it's based on the assumption that the new company would have to buy both the controlling interest shares from Kip and our shares on the open market: they don't have to buy anything on the open market, just rise the authorized shares number and dilute in the run, as does every other company that choose to go public through a reverse merger.
Well, you are very wrong: you are simply saying that every reverse merger with 1000%+ gains we have witnessed should haver never been happened!
Reverse merger in fact works this way:
1) the new management buy the controlling interest, and stop. They don't buy anything on the open market
2) the stock price goes up because of the new company assets, revenues and business plan: people starts buying shares on the open market because they are interested in the new company
3) the new company rises the Authorized shares count and dilute while people is buying
Just see how USSE and every other reverse merger with huge gains worked out.
Moreover, a pink shell is worth 250K dollars. A reporting otc shell is worth 500K dollars. That's why this shell is already underpriced (as you can get control of this with less than 200K dollars).
This may easily reach pennyland (0.02 or more) and even dimeland if they reverse merge with a good company.
Just to give you an example, USSE reached and passed a 400M$ market cap, which would mean dollar land in the case of FNGL!
According to the CEO LifeStem is accepting stem cell donors so it should be operative in the 4 medspas, anyway we didn't get any number.
The problem is that the company should start their marketing campaign as soon as they can... the ceo hinted at this (although he shouldn't write on a message board).
The so called ceo is the ceo, he confirmed this to trusted people.
Two of the company divisions are fully operating and generating revenues (MoleculA and Kd Medical, with their own websites), while LifeStem as far as I know is operative only on 4 Medspas.
Yes it is a great update, especially regarding the OTC listing.
The problem is that the ceo says they don't have money to spend for pr's... but they should do exactly like any other otc and pink company, which repays their pr's campaigns with a little dilution! I really hope that the ceo changes his mind regarding to both stock and company marketing.
Well it's a bit more complicated and in fact they didn't explained it very well... it's going to public as a separate entity on the London Plus Exchange.
So, for example, if they are going to issue 100 million shares of that division, they sell 49 millions of them to the public in London and they keep 51 millions to CLBE, then it would be a subsidiary owned by CLBE but not fully. So for example if you owned 1.3 millions shares of CLBE (1% of CLBE) then you would be the owner of 1% of the 51 millions shares of the UK subsidiary owned by CLBE. CLBE will not issue those UK shares to you as a dividend at first, but they may in the future. I think that's the way it's going to be as they explained in their prs.
The most important thing that matters is that they don't want to dilute CLBE stock but they want to finance the UK division only with the money raised on the London Exchange, so we will not be affected by any diluting in London.
They are not going to dilute anything in the US! They explicitly said that they are going to create this new division as a public entity traded in the London Plus Exchange, thus financing it without any money spent from the US company.
Of course that means that they are going to sell stock on the London Exchange, but that's not the same stock as CLBE.
Anyway according to the CEO they should be getting some financing for CLBE US operations by this timeframe and they should report us about it.
Anyway I think that they would be able to raise some money from this stock too, with the help of serious stock promoters: both the management and us shareholders would benefit about it. A lot of scam masters were able to raise tons of money that way (just think at GBDX and USSE), and a serious company like CLBE isn't able to do that?
Well, it would be worth 25K dollars at that pps... not even bankrupt stocks or CSHD have such a low market cap!!!
This now has a 220K$ market cap... this is really cheap.
Well, retailers flipped for sure and I think that does covered most of the buy volume.
But do you know what you are talking about? This stock is not a diluting nightmare like most pink and otc, and this is severely undervalued even at these prices...
OS should be in the 250M range.
Anyway a fair valuation for an otc reporting shell is 500K dollar, so this will be fairly valued at 0.002 without any further development.
They have a lot of ways to raise money other than dilution and toxic financing (which, by the way, is a thing of the past): they have a lot of intellectual properties to raise money from, plus they can always joint ventures on one of their business.
Well, the only thing we know is that they took care to change the ticker symbol so this is not dead for them.
Of course... but at least this time we have not seen any pumping nor rumors coming out at any level, except someone that started loading up 2 weeks before this name change news (perhaps someone in the know).
Nope and I'm very curious about that. If they changed it without any change in share structure then why they cared? Anyway something should be up.
Something is up with FMGL if they bothered to change the name.
Anyway this company is owned and managed by USEG.
Considering the low float this could run as easily as LFZA... pennyland should not be a problem until a dime. Anyway it all depends on what USEG wants to do with this... anyway if they cared to change their ticker then something should be up.
Yes USEG owns and operates FMGL (tomorrow to be FNGL).
There's a R/S going on here tomorrow. Anyone know how much big will it be?
The positive is that something must be going on, either the reverse merger we were waiting for or the company is going to actively trading again.
Start reasoning in term of market cap.
Now this company has a 1.5M$ market cap.
An otc reporting shell (with no assets or revenues or plan at all) is valued at a 500K$ market cap.
Now with 5M$ you can buy the majority of shares of this company + pay all the debts.
This is undervalued, period.
And talking about dilution going on here... came on, you have never seen real dilution.